These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of maternal zinc supplementation on the development of autism-associated behavioural and synaptic deficits in offspring Shank3-knockout mice. Vyas Y; Lee K; Jung Y; Montgomery JM Mol Brain; 2020 Aug; 13(1):110. PubMed ID: 32758248 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Vicidomini C; Ponzoni L; Lim D; Schmeisser MJ; Reim D; Morello N; Orellana D; Tozzi A; Durante V; Scalmani P; Mantegazza M; Genazzani AA; Giustetto M; Sala M; Calabresi P; Boeckers TM; Sala C; Verpelli C Mol Psychiatry; 2017 May; 22(5):689-702. PubMed ID: 27021819 [TBL] [Abstract][Full Text] [Related]
4. Deletion of the Autism-Associated Protein SHANK3 Abolishes Structural Synaptic Plasticity after Brain Trauma. Urrutia-Ruiz C; Rombach D; Cursano S; Gerlach-Arbeiter S; Schoen M; Bockmann J; Demestre M; Boeckers TM Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682760 [TBL] [Abstract][Full Text] [Related]
5. Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression. Lee K; Vyas Y; Garner CC; Montgomery JM Synapse; 2019 Aug; 73(8):e22097. PubMed ID: 30868621 [TBL] [Abstract][Full Text] [Related]
6. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Bangash MA; Park JM; Melnikova T; Wang D; Jeon SK; Lee D; Syeda S; Kim J; Kouser M; Schwartz J; Cui Y; Zhao X; Speed HE; Kee SE; Tu JC; Hu JH; Petralia RS; Linden DJ; Powell CM; Savonenko A; Xiao B; Worley PF Cell; 2011 May; 145(5):758-72. PubMed ID: 21565394 [TBL] [Abstract][Full Text] [Related]
7. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Wang X; McCoy PA; Rodriguiz RM; Pan Y; Je HS; Roberts AC; Kim CJ; Berrios J; Colvin JS; Bousquet-Moore D; Lorenzo I; Wu G; Weinberg RJ; Ehlers MD; Philpot BD; Beaudet AL; Wetsel WC; Jiang YH Hum Mol Genet; 2011 Aug; 20(15):3093-108. PubMed ID: 21558424 [TBL] [Abstract][Full Text] [Related]
8. Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4-9 Deletion Mouse Model of Autism. Jaramillo TC; Speed HE; Xuan Z; Reimers JM; Liu S; Powell CM Autism Res; 2016 Mar; 9(3):350-75. PubMed ID: 26559786 [TBL] [Abstract][Full Text] [Related]
9. A cross-talk between nitric oxide and the glutamatergic system in a Shank3 mouse model of autism. Hamoudi W; Tripathi MK; Ojha SK; Amal H Free Radic Biol Med; 2022 Aug; 188():83-91. PubMed ID: 35716826 [TBL] [Abstract][Full Text] [Related]
10. GluA1-Shank3 interaction decreases in response to chronic neuronal depolarization. Ross MM; Aizenman E Neurosci Lett; 2023 Jul; 809():137305. PubMed ID: 37210067 [TBL] [Abstract][Full Text] [Related]
11. Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism. Wang W; Li C; Chen Q; van der Goes MS; Hawrot J; Yao AY; Gao X; Lu C; Zang Y; Zhang Q; Lyman K; Wang D; Guo B; Wu S; Gerfen CR; Fu Z; Feng G J Clin Invest; 2017 May; 127(5):1978-1990. PubMed ID: 28414301 [TBL] [Abstract][Full Text] [Related]
12. Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength. Arons MH; Lee K; Thynne CJ; Kim SA; Schob C; Kindler S; Montgomery JM; Garner CC J Neurosci; 2016 Aug; 36(35):9124-34. PubMed ID: 27581454 [TBL] [Abstract][Full Text] [Related]
13. Importance of Shank3 protein in regulating metabotropic glutamate receptor 5 (mGluR5) expression and signaling at synapses. Verpelli C; Dvoretskova E; Vicidomini C; Rossi F; Chiappalone M; Schoen M; Di Stefano B; Mantegazza R; Broccoli V; Böckers TM; Dityatev A; Sala C J Biol Chem; 2011 Oct; 286(40):34839-50. PubMed ID: 21795692 [TBL] [Abstract][Full Text] [Related]
14. Trans-synaptic Association of Vesicular Zinc Transporter 3 and Shank3 Supports Synapse-Specific Dendritic Spine Structure and Function in the Mouse Auditory Cortex. Manning A; Bender PTR; Boyd-Pratt H; Mendelson BZ; Hruska M; Anderson CT J Neurosci; 2024 Jul; 44(28):. PubMed ID: 38830758 [TBL] [Abstract][Full Text] [Related]
16. Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function. Amal H; Barak B; Bhat V; Gong G; Joughin BA; Wang X; Wishnok JS; Feng G; Tannenbaum SR Mol Psychiatry; 2020 Aug; 25(8):1835-1848. PubMed ID: 29988084 [TBL] [Abstract][Full Text] [Related]
17. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder. Fonteneau M; Brugoux A; Jaccaz D; Donello JE; Banerjee P; Le Merrer J; Becker JA Neuropharmacology; 2024 May; 248():109889. PubMed ID: 38401792 [TBL] [Abstract][Full Text] [Related]
18. Dietary Zinc Supplementation Prevents Autism Related Behaviors and Striatal Synaptic Dysfunction in Fourie C; Vyas Y; Lee K; Jung Y; Garner CC; Montgomery JM Front Cell Neurosci; 2018; 12():374. PubMed ID: 30405356 [TBL] [Abstract][Full Text] [Related]
19. SHANK3 Mutations Associated with Autism and Schizophrenia Lead to Shared and Distinct Changes in Dendritic Spine Dynamics in the Developing Mouse Brain. Huang C; Voglewede MM; Ozsen EN; Wang H; Zhang H Neuroscience; 2023 Sep; 528():1-11. PubMed ID: 37532012 [TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Bozdagi O; Sakurai T; Papapetrou D; Wang X; Dickstein DL; Takahashi N; Kajiwara Y; Yang M; Katz AM; Scattoni ML; Harris MJ; Saxena R; Silverman JL; Crawley JN; Zhou Q; Hof PR; Buxbaum JD Mol Autism; 2010 Dec; 1(1):15. PubMed ID: 21167025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]